SPharm Celebrates a Quarter of a Century of Regulatory Affairs Excellence VAL-D’OR, Quebec, Dec. 07, 2022 (GLOBE NEWSWIRE) -- SPharm Inc., one of Canada’s top health products regulatory affairs consulting firms, proudly celebrates 25 years of Regulatory Affairs...

H1N1 Crisis Could Help Lead to Regulatory Efficiencies, Says Cutting Edge Information RESEARCH TRIANGLE PARK, NC--(Marketwire - September 30, 2009) - The FDA has approved the first set of vaccines aimed at preventing H1N1 infection after an approval process of less than four months....